Crossmark

Sarilumab in the management of Graves orbitopathy with low clinical activity scores

Crossref DOI link: https://doi.org/10.1038/s41598-026-35682-4

Published Online: 2026-01-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pérez-Moreiras, José

Abelenda, Dolores

Providência, Joana https://orcid.org/0000-0003-1312-7978
Castela, Guilherme https://orcid.org/0000-0003-0568-8265
License Information

Text and Data Mining valid from 2026-01-14

Version of Record valid from 2026-02-06
More Information

Article History

Received: 4 May 2025

Accepted: 7 January 2026

First Online: 14 January 2026

Declarations

:

: The authors declare no competing interests.